Official UK procurement notice
NHS National Framework for Lenvatinib
Authority: NHS England (Central government)
What is being bought
Published requirement descriptionProject title: NHS National Framework for Lenvatinib
Offer reference number: CM/TNS/26/5751
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5751 Lenvatinib
Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months)
Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months)
Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Framework period
- 1 yr 8 mo · up to 3 yrs 8 mo from 1 Jun 2027
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1RenewalPublished value£35,833,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion: 100%
Published award criteria (1)
- Price is not the only award criterion
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework for Lenvatinib” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Competition analysis · published record, not a forecast of who will bid
How NHS England buys Pharmaceutical products (CPV 3360), and who usually turns up
NHS England’s own published record, next to the published market for the same work. This notice is a framework or DPS, so only frameworks and DPS are compared. Whole-market view: Pharmaceutical products (CPV 3360) →
How the contest usually goes
Winner shares use published awards; bid and price charts use contested lots.
i
How often small and medium firms win.
Share of awards where the winner’s size is known.
The counts under this question show how many awards have a known supplier size.
Small firms have won here. Neither number says whether you qualify; it describes who has been winning.
i
How often local firms win similar work.
Winners with a registered address in the delivery region, out of awards with a known address.
Here, local means the winner is registered in the region where that contract was delivered.
A local branch does not count if the registered address is elsewhere.
Most of this buyer’s recorded winners are registered outside Greater London.
i
How long buyers here take to decide after bids close.
Middle value in days from the deadline to the first award notice, on competitions that published both dates.
Only decided tenders count, so slow ones still waiting are not in.
Half of these awards were announced within 27 days of the bid deadline.
i
How often work is awarded with no recorded rival.
Direct awards and tenders where every published lot count shows one bid.
The market share is a minimum: some awards have no bid count.
Thin markets produce this too; it is not proof of a tailored specification.
Awards are recorded, but published direct routes and bid counts do not establish this buyer’s share.
How many bids did past lots attract?
i
How many bids past lots received.
Each colour is a bid-count range. Only competed lots with a published count are included.
Past bids do not predict this tender.
1 bid14% / 0%
2–322% / 20%
4–615% / 15%
7+48% / 66%
How did awards compare with estimates?
i
Where winning prices landed against estimates.
Each colour shows awards below, close to or above the published estimate, one lot at a time.
On a framework or DPS, prices are agreed when work is called off.
Past prices are a guide, not a bid price.
Not comparable on a framework or DPS. The notice sets up a supplier panel and a ceiling value; what the work actually costs is agreed later, on each call-off or mini-competition, and those publish as contract notices of their own. The award-vs-estimate record of this market therefore sits on the call-offs; this page shows it on the contracts, not on the panel that frames them.
Assess each lot i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
i
What past awards tell you about each lot.
See the forecast, this buyer’s earlier suppliers and firms with relevant wins.
No supplier is confirmed as a bidder.
Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list
Our matching links this notice to “NHS Framework Agreement for Branded Medicines - National Tender” and “NHS National Framework for Transition products commencing 1 May 2024” of this authority, but none of the 13 panel members sit in a category matching this notice.
Lot #1CPV 3360Published estimate£36m
i
How many bids this lot may attract.
The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.
Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative.
A forecast, not a list of bidders.
1 bid1%
2–323%
4–629%
7+47%
i
Where the award price may land.
The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.
No comparable awards for this lot yet.
A statistical guide from past awards, not a price to bid.
Who has supplied this buyer on similar work? i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
i
Who has done similar work for this buyer.
Past contracts are matched by buyer, title and type of work.
A past supplier may not bid again.
| Supplier | This buyer’s earlier contract | Lot | Award value | Why listed |
|---|---|---|---|---|
| NOVARTIS PHARMACEUTICALS UK LIMITEDEarlier contract | NHS National Framework for Transition products (Axitinib and Eltrombopag)started Sept 2025 | — | — | Matched as the earlier contract |
| Ipsen LtdEarlier contract | NHS Framework Agreement for Branded Medicines – Nationalended Apr 2023 | — | — | Matched as the earlier contract |
| Ridge Pharma LimitedEarlier contract | NHS Framework Agreement for Branded Medicines – Nationalended Apr 2023 | — | — | Matched as the earlier contract |
| Biocon Pharma UK LtdEarlier contract | NHS National Framework for Transition products commencing 1 February 2025ended May 2026 | — | — | Matched as the earlier contract |
| ACCORD-UK LTDEarlier contract | NHS National Framework for Transition products (Nilotinib and Ticagrelor)started Aug 2025 | — | — | Matched as the earlier contract |
Who could compete for this lot? i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
i
Who could compete for this lot?
Firms with relevant past wins. On a framework, we show firms on that agreement.
None is confirmed as a bidder.
| Supplier | Won in this category | Live contracts | Award vs estimate |
|---|---|---|---|
| £48m50 awards in 36m · last 1 months ago | 10 live · £6.1m iPublic contracts this supplier still holds. Its awards whose published end date is still in the future, with their values. Many contracts publish no end date, so this is a floor, not the whole book. Unexpired says nothing about spare capacity. | at estimate n=7 | |
Ranbaxy (UK) LtdLarge | £3.0m27 awards in 36m · last 4 months ago | 12 live · £2.8m iPublic contracts this supplier still holds. Its awards whose published end date is still in the future, with their values. Many contracts publish no end date, so this is a floor, not the whole book. Unexpired says nothing about spare capacity. | no comparable pairs |
| £1.5m24 awards in 36m · last 4 months ago | 12 live · £707k iPublic contracts this supplier still holds. Its awards whose published end date is still in the future, with their values. Many contracts publish no end date, so this is a floor, not the whole book. Unexpired says nothing about spare capacity. | no comparable pairs | |
| £1.4m18 awards in 36m · last 4 months ago | 12 live · £1.4m iPublic contracts this supplier still holds. Its awards whose published end date is still in the future, with their values. Many contracts publish no end date, so this is a floor, not the whole book. Unexpired says nothing about spare capacity. | no comparable pairs | |
| £172k28 awards in 36m · last 4 months ago | 11 live · £172k iPublic contracts this supplier still holds. Its awards whose published end date is still in the future, with their values. Many contracts publish no end date, so this is a floor, not the whole book. Unexpired says nothing about spare capacity. | no comparable pairs |
About this data
- Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
- Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
- Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
- Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Open admission
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 23 Apr 2026, 08:14 BST
- Last source update
- 30 Sept 2026, 14:30 BST
- Award evaluation window
- Submission end – 25 Nov 2026
- Authority reference
CM/TNS/26/5751- FTS notice number
2026/S 000-092421- Latest notice
- Tender notice (UK4)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06891aFind a Tender
How to participate & submission route
Official notice Apply via Atamis legacy domain (health-family.force.com)- Requests to participate (first stage)
- —
- Appointment period ends
- 30 Oct 2026, 13:00 GMT
- Clarification deadline
- 23 Oct 2026, 13:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional info obtained from the abovementioned address
Tenders must be submitted to the abovementioned address
Timeline
23 Apr 2026 → 1 Jun 2027 · 8 dates- Planning notice published182 days ago23 Apr 2026, 08:14 BST
- Market engagement77 days ago5 Aug 2026, 23:59 BST
NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
- Tender notice published21 days ago30 Sept 2026, 14:30 BST
- Next notice expected21 days ago30 Sept 2026, 23:59 BST
- Today21 Oct 2026
- Clarification questions byin 2 days23 Oct 2026, 13:00 BST
- Admission / appointment period endsin 9 days · period end, not a bid countdown30 Oct 2026, 13:00 GMT
- Award decision expected byin 35 days25 Nov 2026, 23:59 GMT
- Contract startsin 222 days1 Jun 2027, 00:00 BST
Notice history
8 events · 5 releases on Find a Tender · since 23 Apr 2026- Pipeline notice published23 Apr 2026, 08:14 BSTUK1
- Pipeline notice published23 Apr 2026, 08:26 BSTUK1
- Pipeline notice published15 Jul 2026, 09:55 BSTUK1
- Preliminary market engagement notice published22 Jul 2026, 12:36 BSTUK2
- Published value updated to £35,833,00022 Jul 2026, 12:36 BSTwas £10,100,000
- Tender notice published30 Sept 2026, 14:30 BSTUK4
- Status changed to active30 Sept 2026, 14:30 BST
- Deadline published: 30 Oct 2026, 13:00 GMT30 Sept 2026, 14:30 BST
Published amendments (2)
Title amendment
Estimated Publication Date changed from 01/08/2026 to 30/09/2026
Routine re-releases (5)
- 2026-04: 2 releases · 23 Apr 2026, 23 Apr 2026
Commercial outcome & contract awards
Nothing awarded yet- Awards (0)
- No award published
- Contracts (0)
- No contract published
- Bid statistics
- No aggregate bid statistics published
Contracting authority & participating public bodies
Official documents & specifications (17)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications Document No. 05a Selectt offer schedule - CM_TNS_26_5751_01
- Bidding documents and specifications Document No. 05b Tender Product Listing and Usage - CM-TNS-26-5751
- Bidding documents and specifications Document No. 06 - Form of offer - CM-TNS-26-5751
- Bidding documents and specifications Document No. 07 - Quality control technical sheet - CM-TNS-26-5751
- Bidding documents and specifications Document No. 01 - Invitation to offer covering letter - CM-TNS-26-5751
- Bidding documents and specifications Document No. 09 - Pharmacy Purchasing Points List - CM-TNS-26-5751
- Bidding documents and specifications Document No. 10 - Requirement Section 1. Procurement Specific Questionnaire (PSQ) - CM-TNS-26-5751
- Bidding documents and specifications Document No. 08 - Confidential information schedule - CM-TNS-26-5751
Show 4 more documents
- Bidding documents and specifications Document No. 02 - Terms of offer - CM-TNS-26-5751
- Bidding documents and specifications Document No. 03 - Framework Agreement and Terms and Conditions - CM-TNS-26-5751
- Bidding documents and specifications Document No. 04 - Quality Assurance Process - CM-TNS-26-5751
- Bidding documents and specifications Document No. 05 - Selectt offer schedule instructions - CM-TNS-26-5751
Notices published for this procedure
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender